Necessary diagnostic and investigative procedures along with PET/CT for accurate cancer staging and treatment response assessment will be available at NMICC
Nanavati Max Super Speciality Hospital, Mumbai (NMICC) has announced scaling-up of its cancer care offerings by on-boarding a team of internationally acclaimed cancer specialists.
NMICC aims to augment the scope of cancer diagnosis and treatment with a holistic approach in Western India. The institute will offer patient care through Disease Management Groups (DMG) specialised in management of Head and Neck, Breast, Gynaecological, Hepatobiliary and Gastrointestinal, Orthopaedic and Haematological cancers to name a few.
NMICC will launch the rare Onco-Robotic surgery program assisted by latest Da Vinci Xi robotic surgical system. The institute will offer comprehensive range of diagnostic, medical and surgical services through advanced technologies such as Halcyon—the latest linear accelerator and HIPEC (Hyperthermic Intraperitoneal Chemotherapy) and also advanced surgical procedures such as limb salvage cancer surgery, breast reconstruction and oncoplasty, head and neck surgery with reconstruction and fertility preservation for gynaecological cancers. Necessary diagnostic and investigative procedures along with PET/CT for accurate cancer staging and treatment response assessment will be available at NMICC.
Commenting on the augmentation of onco-sciences offerings, Mangla Dembi, Senior Vice President and Head, Nanavati Max Super Speciality Hospital said, “With dedicated infrastructure and technology, NMICC represents our commitment of focused and quality cancer care for all our patients alike. A multi-disciplinary approach through innovative treatment methodologies and prodigious clinical expertise will make NMICC the ground zero for India’s fight against cancer.”
The institute will also focus on psychological support and counselling of cancer patients and their families. Through disease specific support group programs, the institute will promote sharing of personal experiences, coping mechanisms and latest disease trends among doctors, cancer survivors and their families.